It has been suggested that activation of PPARα may protect against hepatic steatosis (Beyoğlu and Idle, 2013; Yang et al., 2016; Chascsa et al., 2017) Feno effectively improved the atherogenic lipid profile associated with T2DM by activating PPARα(Rosenson, 2009). This evidence concerns the gene PPARA and fatty liver disease.